In vitro diagnostics for the medical dermatologist. Part II: Hypercoagulability tests.
J Am Acad Dermatol
; 85(2): 301-310, 2021 08.
Article
in English
| MEDLINE | ID: covidwho-1379127
ABSTRACT
The skin often provides initial clues of hypercoagulability with features such as livedo reticularis, livedo racemosa, retiform purpura, necrosis, and ulcerations. Because these cutaneous manifestations are nonspecific, laboratory testing is often needed to evaluate for underlying causes of hypercoagulability. Importantly, these disorders are reported to be the most common mimicker, resulting in an erroneous diagnosis of pyoderma gangrenosum. Understanding inherent properties of, and indications for, available tests is necessary for appropriate ordering and interpretation of results. Additionally, ordering of these tests in an indiscriminate manner may lead to inaccurate results, complicating the interpretation and approach to management. This second article in this continuing medical education series summarizes information on methodology, test characteristics, and limitations of several in vitro laboratory tests used for the work up of hypercoagulability and vasculopathic disease as it pertains to dermatologic disease.
Keywords
D-dimer; antiphospholipid antibodies; cryofibrinogenemia; cryoglobulinemia; diagnostic testing; factor deficiency; genetic thrombophilia; hereditary thrombophilia; hypercoagulability; medical dermatology; monoclonal gammopathy; multiple myeloma; pyoderma gangrenosum; retiform purpura; thrombogenic vasculopathy; thrombotic vasculopathy; ulcer
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Skin Diseases
/
Thrombophilia
Type of study:
Diagnostic study
/
Experimental Studies
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
J Am Acad Dermatol
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS